{
    "nct_id": "NCT03251027",
    "official_title": "Intensity-Modulated Stereotactic Radiotherapy as an Upfront Scalp-Sparing Intervention for the Treatment of Newly Diagnosed Grade II-IV Gliomas",
    "inclusion_criteria": "* Patients must have histologically confirmed low or high grade glioma (grade II-IV)\n* Karnofsky performance status (KPS) >= 60\n* Patients must have recovered from the effects of surgery; there must be a minimum of 21 days from the day of surgery to the day of protocol treatment\n* Estimated survival >= 3 months\n* Labs considered acceptable per standard of care\n* Patient must sign a study specific informed consent form\n* Radiation treatment must begin >= 3 weeks and =< 8 weeks after surgery\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Prior history of scalp radiation or intolerance to standard course of radiation treatment\n* Co-morbidities that would influence wound healing including diabetes (insulin dependent) or smoking (current ongoing use)\n* Pregnancy or women of childbearing potential and men who are sexually active and not willing/able to use medically acceptable forms of contraception\n* Karnofsky performance status (KPS) < 60\n* Patient can't have magnetic resonance imaging (MRI) scan\n* Active collagen vascular disease",
    "miscellaneous_criteria": ""
}